washington reuters democratic presidential candidate hillary clinton call pharmaceutical company mylan nv voluntarily drop price severe allergy treatment drug epipen increase price 400 percent past decade
“ ’ outrageous ’ latest troubling example company take advantage consumer ” clinton say statement
“ ’ wrong drug company put profit ahead patient raise price without justify value behind ” clinton frequently say primary would fight pharmaceutical company part attempt counter criticism closely tie insurance industry
release proposal say lower drug cost consumer
mylan spokeswoman nina devlin respond inquiry clinton ’ criticism company
mylan acquire product 2007 price increase 100 2008 current cost 600
share mylan close 5 percent 4315 nasdaq
“ price epipen outrageous ” say robert weissman president consumer watchdog group public citizen
“ mylan endanger life rip country ” weissman say epipen ’ u price roll back sharply note product available little 112 canada
many drugmakers also routinely raise price prescription drug 10 percent year u legislation need prevent “ price spike ” add
white house take cautious tone criticize rise drug cost refuse comment decision individual company
“ observe however pharmaceutical company often try portray inventor lifesaving medication often real damage reputation greedy jack price way victimize ” white house spokesman josh earnest say news briefing
clinton join bipartisan group lawmaker call investigation price increase epipens preloaded injection epinephrine adrenaline people use dangerous allergic reaction untreated could result death
republican senator chuck grassley chairman senate judiciary committee write mylan earlier week ask explanation price change
senator amy klobuchar top democrat committee ’ antitrust subcommittee call investigation federal trade commission
wednesday republican senator susan collins democratic senator claire mccaskill request mylan provide briefing senate explain price change
grassley klobuchar along democratic senator patrick leahy richard blumenthal republican senator ron johnson wednesday say write food drug administration ask approval process alternative epipen
“ give importance topic imperative understand fda ’ role respect epipens approval generic equivalent could help increase competition lower price introduce ” senator say statement
“ reach every member congress send u letter look forward meet respond question soon possible ” devlin say
january clinton admonish valeant pharmaceutical international inc raise price heart drug
wake clinton campaign blog post target valeant company ’ stock fell
march release campaign ad vow target company specifically
clinton also criticize turing pharmaceutical fall 2015 public ire rise decide raise price antiviral medication commonly use aid patient pregnant woman 1350 tablet 750
single post clinton social medium website twitter critical turing company ’ stock price tumble
time clinton release comprehensive drug price plan say would reduce cost
proposal include cap monthly outofpocket cost expand generic drug access allow american buy pharmaceutical abroad
republican presidential candidate donald trump say little lower drug price
propose increase amount negotiation permit medicare order lower price use program